Merck KGaA Subsidiary Teams Up with Aulos Bioscience to Test PD-L1 and Anti-IL-2 Combination
Germany’s Merck KGaA (ETR: MRK) has announced that its Switzerland-based subsidiary, Ares Trading, has entered...
Company
Chunlizhengda’s Handheld Orthopedic Robot Approved by China’s NMPA
Beijing Chunlizhengda Medical Instruments Co., Ltd (HKG: 1858, SHA: 688236) has received marketing approval from...
Roche Marks 30 Years in China with Commitment to Boost Investments and Local Manufacturing
Roche (SWX: ROG), the Swiss pharmaceutical giant, has reaffirmed its long-term commitment to the Chinese...
Hengrui Pharmaceuticals Strikes Deal with Hercules CM Newco to Supply GLP-1 Products for Global Markets
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading Chinese pharmaceutical company, has entered into...
Roc Rock Biotechnology Secures Ethical Approval for CAR-M Therapy in Ovarian Cancer
China-based Roc Rock Biotechnology Co., Ltd. has announced that it has received ethical approval from...
Novo Holdings Gains Controlling Interest in Biopharma Equipment Supplier Single Use Support
Novo Nordisk’s (CPH: NOVO-B) controlling shareholder, Novo Holdings, has entered into an agreement to purchase...
AstraZeneca and BenevolentAI Reach Milestone in Heart Failure Target Validation
AstraZeneca (AZ; NASDAQ: AZN) has announced the successful experimental validation of a groundbreaking heart failure...
Sunho Biologics Lists on HKEX with HKD 461 Million Biotech IPO
Sunho Biologics, Inc., (HKG: 2898) a clinical-stage biopharmaceutical company based in China specializing in biologic...
Lifetech Scientific’s IBS Stent Demonstrates Non-Inferiority in Phase II Trial
Lifetech Scientific Corporation (HKG: 1302), a biopharmaceutical company based in China, has announced the completion...
Olymvax Biopharmaceuticals Gets Green Light for Tetravalent Influenza Vaccine Clinical Trial
Olymvax Biopharmaceuticals Inc. (SHA: 688319), a leading vaccine specialist headquartered in Chengdu, China, has announced...
Insilico Medicine’s ISM8207 Enters Phase I Clinical Trial for Lymphoma and Solid Tumors
China’s generative artificial intelligence (AI)-driven biotech firm, Insilico Medicine, has announced the first patient dosing...
GE HealthCare Partners with Shanghai Pudong for USD 52.5 Million Medical Tech Investment
GE HealthCare (NASDAQ: GEHC), a leading medical technology firm, has entered into a cooperation intent...
Vision Medicals Raises Hundreds of Millions in Series D+ Round to Advance Molecular Diagnostics
Guangdong-based Vision Medicals has reportedly secured hundreds of millions of renminbi in a Series D+...
Nabla Bio Forges Partnerships with Top Pharma Companies to Tackle Challenging Drug Targets
Protein design specialist Nabla Bio has announced strategic collaborations with pharmaceutical giants AstraZeneca (AZ; NASDAQ:...
Eli Lilly & Co. Expands Clinical Collaboration with Shanghai East Hospital in China
Eli Lilly & Co. (NYSE: LLY), a leading global pharmaceutical company, has announced an expansion...
Everest Medicines Commences Commercial Sales of Nefecon in China Post-Launch
Everest Medicines (HKG: 1952), a leading pharmaceutical company based in China, has announced the official...
Elite (Suzhou) Analytical Instruments Boosts Liquid Chromatography Push with Series A+ Round
China-based Elite (Suzhou) Analytical Instruments Co., Ltd, a premier manufacturer of liquid chromatography devices in...
US Readies Hefty Tariffs on Chinese Medical Equipment and Other Imports
The US Office of the Trade Representative (USTR) has announced a series of stringent new...
Genmab CEO Cites China’s Biotech as a ‘Mind-Boggling’ Source of Innovation
Jan van de Winkel, CEO of Denmark-based biotech Genmab (NASDAQ: GMAB), has expressed optimism about...
Fosun Pharmaceutical Advances Lasofocine Clinical Trials for Breast Cancer after NMPA Nod
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has announced that it has...